Evaluation and management of acute ischemic stroke

CONTINUUM Lifelong Learning in Neurology

Volumn 20, Issue 2, 2014, Pages 283-295

  Khatri, Pooja ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; GLUCOSE;

BLOOD CLOT LYSIS; BLOOD PRESSURE; BRAIN ISCHEMIA; CLINICAL DECISION MAKING; GLUCOSE BLOOD LEVEL; HUMAN; MEDICAL DECISION MAKING; MEDICAL HISTORY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; REPERFUSION; REVIEW; STROKE PATIENT; TIME;

EID: 84898615073     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000446101.44302.47     Document Type: Review

References (31)

1. Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44(3):870-947.
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke StudyGroup.NEngl JMed 1995;333(24): 1581-1587.
3. Hacke W, Donnan G, Fieschi C, et al; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363(9411):768-774.
4. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375(9727):1695-1703.
5. Khatri P, Abruzzo T, Yeatts SD, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73(13):1066-1072.
6. Marler JR, Jones PW, Emr W. Proceedings of a national symposium on rapid identification and treatment of acute stroke. Bethesda, MD: The National Institute of Neurologic Disorders and Stroke (NINDS), National Institutes of Health, 1997;97:4239.
7. Saver JL. Thrombolytic therapy in stroke. Medscape. emedicine.medscape. com/article/ 1160840-overview. Updated September 18, 2012. Accessed February 6, 2014.
8. Gadhia J, Starkman S, Ovbiagele B, et al. Assessment and improvement of figures to visually convey benefit and risk of stroke thrombolysis. Stroke 2010;41(2):300-306.
9. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 2003;34(12):2847-2850.
10. The IST3 Collaborative Group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012;379(9834):2352-2363.
11. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282(21):2003-2011.
12. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38(10): 2633-2639.
13. Fields JD, Khatri P, Nesbit GM, et al. Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion. JNeurointerv Surg 2011;3(2):151-155.
14. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versusMerci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380(9849):1231-1240.
15. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380(9849): 1241-1249.
16. Bose A, Henkes H, Alfke K, et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29(7):1409-1413.
17. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368(10):904-913.
18. Chalela JA, Katzan I, LiebeskindDS, et al. Safety of intra-arterial thrombolysis in the postoperative period. Stroke 2001;32(6), 1365-1369.
19. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368(10):914-923.
20. Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012;11(10):860-867.
21. Jovin TG, Liebeskind DS, Gupta R, et al. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke 2011;42(8): 2206-2211.
22. Parsons MW, Albers GW. MR RESCUE: is the glass half-full or half-empty? Stroke 2013;44(7):2055-2057.
23. The Re-examining Acute Eligibility for Thrombolysis (TREAT) Task Force; Levine SR, Khatri P, Broderick JP, et al. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria part 1: rapidly improving stroke symptoms. Stroke 2013;44(7):2055-2057.
24. Tsivgoulis G, Alexandrov AV, Chang J, et al. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke 2011;42(6):1771-1774.
25. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368(10):893- 903.
26. Cucchiara BL, Jackson B, Weiner M, Messe SR. Usefulness of checking platelet count before thrombolysis in acute ischemic stroke. Stroke 2007;38(5):1639-1640.
27. Rost NS, Masrur S, Pervez MA, et al. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology 2009;73(23):1957-1962.
28. Demchuk AM, Hill MD, Barber PA, et al. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 2005;36(10): 2110-2115.
29. CAST: randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349(9066):1641-1649.
30. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among19435 patients with acute ischaemic stroke. Lancet 1997;349(9065):1569-1581.
31. Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013;369(1):11-19